Ventas, Inc.

BOVESPA:V1TA34 Stock Report

Market Cap: R$151.4b

Ventas Past Earnings Performance

Past criteria checks 0/6

Ventas's earnings have been declining at an average annual rate of -67.9%, while the Health Care REITs industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 4.7% per year.

Key information

-67.9%

Earnings growth rate

-68.4%

EPS growth rate

Health Care REITs Industry Growth0.6%
Revenue growth rate4.7%
Return on equity-0.5%
Net Margin-1.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Ventas makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BOVESPA:V1TA34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,797-671580
30 Jun 244,706-1571560
31 Mar 244,615-731530
31 Dec 234,500-411490
30 Sep 234,35951460
30 Jun 234,256771480
31 Mar 234,173-691470
31 Dec 224,116-471450
30 Sep 224,079-431400
30 Jun 224,019161350
31 Mar 223,9211451320
31 Dec 213,818491300
30 Sep 213,7602001310
30 Jun 213,7011521330
31 Mar 213,703-911300
31 Dec 203,7904391300
30 Sep 203,8473401350
30 Jun 203,9114131430
31 Mar 203,9257801580
31 Dec 193,8594331590
30 Sep 193,7814841630
30 Jun 193,7205011620
31 Mar 193,7144571560
31 Dec 183,7024091460
30 Sep 183,6687401480
30 Jun 183,6461,2521420
31 Mar 183,6071,2371390
31 Dec 173,5681,3571350
30 Sep 173,5601,1721320
30 Jun 173,5277071300
31 Mar 173,4816991290
31 Dec 163,4476501270
30 Sep 163,4105691230
30 Jun 163,3694651240
31 Mar 163,3314531250
31 Dec 153,2844071280
30 Sep 153,1713661290
30 Jun 153,0494121260
31 Mar 152,8363611230
31 Dec 142,7723761220
30 Sep 142,7763981240
30 Jun 142,7834351230
31 Mar 142,8684871190

Quality Earnings: V1TA34 is currently unprofitable.

Growing Profit Margin: V1TA34 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: V1TA34 is unprofitable, and losses have increased over the past 5 years at a rate of 67.9% per year.

Accelerating Growth: Unable to compare V1TA34's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: V1TA34 is unprofitable, making it difficult to compare its past year earnings growth to the Health Care REITs industry (29.2%).

Return on Equity

High ROE: V1TA34 has a negative Return on Equity (-0.54%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 19:50
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ventas, Inc. is covered by 43 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jacob KilsteinArgus Research Company
David RodgersBaird
Amanda SweitzerBaird